Victor Levitsky

2.5k total citations · 1 hit paper
41 papers, 1.9k citations indexed

About

Victor Levitsky is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Victor Levitsky has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Immunology and 14 papers in Epidemiology. Recurrent topics in Victor Levitsky's work include Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (15 papers) and Cytomegalovirus and herpesvirus research (12 papers). Victor Levitsky is often cited by papers focused on Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (15 papers) and Cytomegalovirus and herpesvirus research (12 papers). Victor Levitsky collaborates with scholars based in Sweden, United States and Spain. Victor Levitsky's co-authors include Maria G. Masucci, Jelena Levitskaya, Michael G. Kurilla, Stefan Imreh, George Klein, Teresa Frisan, Pedro O. de Campos‐Lima, Olle Ringdén, Jie‐Zhi Zou and Jacek Winiarski and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Victor Levitsky

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

1995 634 citations Jelena Levitskaya, Victor Levitsky et al. Nature profile →

Peers

Countries citing papers authored by Victor Levitsky

Since Specialization

Citations

This map shows the geographic impact of Victor Levitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Levitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Levitsky more than expected).

Fields of papers citing papers by Victor Levitsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Levitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Levitsky. The network helps show where Victor Levitsky may publish in the future.

Co-authorship network of co-authors of Victor Levitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Levitsky. A scholar is included among the top collaborators of Victor Levitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Levitsky. Victor Levitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment	Journal for ImmunoTherapy of Cancer	Santiago Ponce, S. Cedrés et al.	16
2	A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression	Cancer Immunology Research	Nicolò Rigamonti, Niina Veitonmäki et al.	18
3	Profound Functional Suppression of Tumor‐Infiltrating T‐Cells in Ovarian Cancer Patients Can Be Reversed Using PD‐1‐Blocking Antibodies or DARPin® Proteins	Journal of Immunology Research	Esther Schoutrop, Anette Mörtberg et al.	9
4	Abstract B026: Development of tumor-targeted agonistic Immunomodulators using the DARPin® technology platform	Cancer Immunology Research	Victor Levitsky, Elmar vom Baur et al.	1
5	Abstract 3251: Fibroblast activation protein (FAP)-selective delivery of CD40 agonistic DARPin®molecule for tumor-localized immune activation	Cancer Research	Nicolò Rigamonti, Anja Schlegel et al.	1
6	Abstract 3752: Preclinical pharmacology of MP0310: A 4-1BB/FAP bispecific DARPin drug candidate promoting tumor-restricted T-cell costimulation	Cancer Research	Julia Hepp, Christian Reichen et al.	3
7	Dynamics of the Major Histocompatibility Complex Class I Processing and Presentation Pathway in the Course of Malaria Parasite Development in Human Hepatocytes: Implications for Vaccine Development	PLoS ONE	Jinxia Ma, Peter C. Dumoulin et al.	11
8	Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules	Journal of Cellular and Molecular Medicine	Jinxia Ma, André Ortlieb Guerreiro‐Cacais et al.	25
9	A Molecular Link between Malaria and Epstein–Barr Virus Reactivation	PLoS Pathogens	Arnaud Chêne, Daria Donati et al.	131
10	T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ production	International Immunology	Niels Schaft, Joost Drexhage et al.	40
11	Identification of an immunodominant H‐2D^b‐restricted CTL epitope of human PSA	The Prostate	Maxim Pavlenko, Christoph Leder et al.	20
12	Determination of Antigen and Fine Peptide Specificity of EBV-Specific CTLs	Humana Press eBooks	Victor Levitsky, Teresa Frisan et al.	0
13	Limiting Dilution Assay	Humana Press eBooks	Teresa Frisan, Victor Levitsky et al.	10
14	Generation of Lymphoblastoid Cell Lines (LCLs)	Humana Press eBooks	Teresa Frisan, Victor Levitsky et al.	22
15	Generation of Polyclonal EBV-Specific CTL Cultures and Clones	Humana Press eBooks	Victor Levitsky, Teresa Frisan et al.	2
16	Cytolytic T Cell Reactivity to Epstein-Barr Virus Is Lost During In Vitro T Cell Expansion	Journal of Hematotherapy & Stem Cell Research	Stefan Carlens, Olle Ringdén et al.	9
17	Manipulation of immune responses by Epstein–Barr virus	Virus Research	Victor Levitsky, Maria G. Masucci	27
18	The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.	The Journal of Experimental Medicine	Victor Levitsky, Maria G. Masucci et al.	112
19	Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 breakdown →	Nature	Jelena Levitskaya, Victor Levitsky et al.	634
20	T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.	The Journal of Experimental Medicine	Pedro O. de Campos‐Lima, Victor Levitsky et al.	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact